KLI

HPV 양성 두경부암에서 방사선 저항성 예측 바이오마커 개발: TP53 mutation 및 SOX2 역할 규명

Metadata Downloads
Abstract
Abstract
Background: HPV-positive OPSCC patients tend to be non/low-smokers and drinkers, as well as younger and overall healthier than their HPV-negative counterparts. Given the high survivorship in HPV-positive OPSCC, there is great interest in de-intensifying therapy. However, approximately 15% of HPV-positive OPSCC patients fail standard therapy. Robust biomarkers of radiation resistance would be highly useful to exclude high-risk patients from deintensification protocols and instead direct them towards intensified treatment. The aim of this study is to validate the molecular subgroups presenting radiation resistance and investigate the mechanism of tumor aggressiveness and radiation resistance in HPV-positive OPSCC

Methods: We introduced the TP53 mutation into two novel, treatment naive HPV-positive cell line. MTT assay, migration and invasion assay and clonogenic assay was performed to compare the tumor growth, aggressiveness and radiation resistance in both parental and TP53 mutation cell line in vitro. Microarray and western blot were performed to detect robust biomarkers in TP53 mutation HPV-positive cell line compared with parental cell line. We confirmed the in vitro data through in vivo study.

Results: TP53 mutation cell line with increased ability of migration and invasiveness showed resistance to radiation compared to TP53 wild HPV-positive cell line. We found that SOX2 was expressed predominantly in the TP53 mutation cell line on microarray and confirmed the findings through western blot. And we demonstrated that SOX2 mediated the tumor migration and invasiveness and radiation resistance in TP53 mutation cell lines. Inhibition of SOX2 enhanced radiation sensitivity in the TP53 mutation cell line in vitro and in vivo study.

Conclusions: SOX2 is overexpressed in TP53 mutation HPV-positive OPSCC and plays a crucial role in the development of radiation resistance by regulating tumor invasiveness.
Author(s)
김태군
Issued Date
2022
Awarded Date
2022-08
Type
dissertation
Keyword
human papillomavirus-associated oropharyngeal cancerTP53 mutationsex-determining region Y-box 2 (SOX2)
URI
https://oak.ulsan.ac.kr/handle/2021.oak/9972
http://ulsan.dcollection.net/common/orgView/200000632622
Alternative Author(s)
Tae-koon Kim
Affiliation
울산대학교
Department
일반대학원 의학과
Advisor
한명월
Degree
Master
Publisher
울산대학교 일반대학원 의학과
Language
eng
Rights
울산대학교 논문은 저작권에 의해 보호 받습니다.
Appears in Collections:
Medicine > 1. Theses (Master)
Authorize & License
  • Authorize공개
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.